Aurobindo Pharma Q3 results: Net profit jumps 90% to Rs 936.2 crore
Earlier, Aurobindo Pharma reported an 85 percent year-on-year rise in consolidated net profit to Rs 757 crore in the July-September quarter
Earlier, Aurobindo Pharma reported an 85 percent year-on-year rise in consolidated net profit to Rs 757 crore in the July-September quarter Earlier, Aurobindo Pharma reported an 85 percent year-on-year rise in consolidated net profit to Rs 757 crore in the July-September quarter Moneycontrol Latest News Read More
Earlier, Aurobindo Pharma reported an 85 percent year-on-year rise in consolidated net profit to Rs 757 crore in the July-September quarter








